Advertisement · 728 × 90
#
Hashtag
#HBV
Advertisement · 728 × 90

Liebe Kolleginnen und Kollegen,

Bitte Gesundheituntersuchung mit Screening auf #HBV und #HCV anbieten.

Tatsächlich scheint es Kollegen und Kolleginnen zu geben nicht wissen das man diese präventiv Laborleistung ohne Budgetbelastung machen kann.

#aids #aidstageberlin

3 0 0 0
Preview
A tribute to Dr Ahmed Elsharkawy We are deeply saddened by the passing of Dr Ahmed Elsharkawy, a dedicated trustee of the British …

In honour of @ahmedelsharkawy.bsky.social, a colleague, collaborator & friend for 25 yrs, and a wise, knowledgeable, & dedicated doctor working in support of patient voice.
Sadly missed but his legacy continues. #HBV #MedSky #LiverSky @easlnews.bsky.social
britishlivertrust.org.uk/a-tribute-to...

2 0 0 0
Genotype switching in hepatitis B virus as a potential risk for vertical transmission from mother-to-child was first reported

Genotype switching in hepatitis B virus as a potential risk for vertical transmission from mother-to-child was first reported

This study reports #HBV #MTCT despite reduced maternal viral loads & infant #immunoprophylaxis, showing #ViralLoad is key but not the sole factor; genotype switching and #quasispecies diversity reveal added mechanisms in transmission. #PublicHealth

#OpenAccess: doi.org/10.1016/j.dc...

0 0 0 0
Post image

Steatosis Paradox:

Unraveling Pathways of Suppressive Effect of Hepatic #Steatosis on #Hepatitis B Virus

www.sciencedirect.com/science/arti... #OpenAccess #HBV #MicroSky #MedSky

0 0 0 0
Post image

Viral genotype changes can influence transmission pathways. Research on hepatitis B virus genotype switching highlights implications for vertical transmission and infection risk.
doi.org/10.1016/j.dc...
#HepatitisB #ViralGenomics #GenotypeSwitching #MotherToChildTransmission #HBV

1 0 0 0

Very proud to release this work! - huge collaboration to assess #HBV #epidemiology ( #infection & #immunity) in a large population study in #SouthAfrica. High prevalence, high #treatment need, low #vaccine mediated protection.
@crick.ac.uk @uclnews.bsky.social @ahri-news.bsky.social
🧪 #MedSky

2 2 0 0
Preview
a happy 25th anniversary greeting card with balloons and confetti ALT: a happy 25th anniversary greeting card with balloons and confetti

Doch erst so jung? 😊 Dachte der Zusammenschluss von #HBV (Handel, Banken und Versicherungen) und #ÖTV (Öffentliche Dienste, Transport und Verkehr) liegt länger zurück. 🤦, zu dem was man zur Zeit an verschiedenen Stellen an Äußerungen wegen dem #Warnstreik liest.

0 0 1 0
Preview
HIV vs Hepatitis B: Which Infection Is More Dangerous for Your Health? Discover the key differences between HIV and Hepatitis B. Learn about transmission rates, mortality statistics, and long-term health impacts to understand which virus poses a greater risk today.

Is Hepatitis B more dangerous than HIV? Compare the infectiousness, mortality rates, and health risks of HBV and HIV. Learn which virus is harder to kill and how to protect yourself.
mrmed-6851.freshlearn.com/blog/14303

#HealthAwareness #HIV #HepatitisB #HBV #SexualHealth #LiverHealth

0 1 0 0
Preview
Hepatic Viral Reservoirs in HIV/HBV Coinfection: Mechanisms of Persist | IDR This review integrates mechanistic, clinical, and community perspectives to provide a unified framework for understanding concurrent HIV and HBV.

Hepatic Viral Reservoirs in Concurrent #HIV and #HBV: From Mechanistic Insight to Integrated Cure Strategies www.dovepress.com/hepatic-vira... (open access review)

1 1 0 0
Post image

📊 CHB patients on Peg-IFN:

✅ HBsAg decline at wk24 & baseline HBsAg best predict functional cure.
✅ HBV RNA & HBeAg levels (wk12/24) best predict HBeAg loss.

Guiding personalized therapy.
👥 @HenryEChang@asianliverctr

#Hepatology #HBV #LiverTwitter

👉 www.xiahepublishing.com/2310-8819/JC...

0 0 0 0

Lots of learning & dialogue about how we strengthen equitable North-South partnerships, gain from bilateral capacity building, improve community co-design & invest in skills exchange for #HBV #hepatitis #research. 🧪
@ice-hbv.bsky.social @who.int @sdgactioncampaign.org
#MedSky #LiverSky #elimination

7 4 0 0
Post image

Genotype switching in hepatitis B virus highlights how viral genetic variation may influence mother-to-child transmission dynamics.
doi.org/10.1016/j.dc...
#HepatitisB #ViralGenomics #GenotypeSwitching #MotherToChildTransmission #HBV

2 1 1 0
MASLD and viral hepatitis overlap: An emerging dual burden in chronic liver disease — Hepatology Forum Hepatology Forum is an open access journal publishing clinical and translational research in hepatology and liver diseases.

#MASLD and #HBV overlap tackled in this article - lots of questions remaining in how to assess and treat this emerging dual threat to global #liver health 🧪
#MedSKy #LiverSky #HepSky #hepatitis
hepatologyforum.org/article/257

0 0 0 0

Excellent work led by Ricky Sinharay showing cost-effectiveness of expanding #HBV treatment, which supports scale-up to reduce complications & mortality 🧪
@england.nhs.uk @royalberkshospital.bsky.social @easlnews.bsky.social @who.int
#LiverSky #MedSky #hepatitis #BASL
fg.bmj.com/content/earl...

0 0 0 0

British Association for Study of the #Liver discussion on #treatment & #cancer #surveillance for people living with #HBV - we should treat all who need surveillance, but surveillance not necessary for all on treatment. Important to unify clinical & public health approaches. 🧪 #BASL #BVHG #LiverSky

1 0 0 1
Preview
Long-Acting ART Possible Therapeutic Option for HIV With Prior HBV Exposure Switching to long-acting antiretroviral therapy (ART) with cabotegravir (CAB) plus rilpivirine (RPV) does not appear to increase risk for hepatitis B virus (HBV) reactivation or incident infection in ...

Among patients with #HIV, standardized protocols are necessary to ensure #HBV screening occurs before initiating antiretroviral therapy regimens that lack anti-HBV activity, including long-acting cabotegravir plus rilpivirine.

Read More: https://bit.ly/4r33FO2

0 0 0 0
Post image

Predicting PEG-IFN response in hepatitis B: HBsAg decline at week 24 best predicts functional cure. For HBeAg loss, HBV RNA & HBeAg levels at week 12 are key. Better markers = tailored therapy. #HBV #HepatitisB #LiverTwitter

2 0 0 0
Post image

Promising findings by Hiroshima University researchers. In chronic #HepatitisB #HepB, #HBV #RNA may better predict #livercancer risk than current markers, even when viral DNA is undetectable. This could help identify patients who need closer monitoring earlier. www.linkedin.com/posts/drmelv...

1 0 0 0

#Nedsky🧪 #IDsky #pedsky #immunosky #publichealth @jama.com #HBV vaccination has substantially ⏬️ HBV-related morbidity & mortality.Infants infected with HBV in the first year of life have a 90% risk of developing chronic infection, which is associated with chronic #liverdisease

1 0 1 0
Post image

This study reports rare #HBV #MothertoChild transmission despite low maternal viral load & neonatal #immunoprophylaxis, revealing genotype switching & quasispecies diversity, underscoring mechanisms beyond #viralload.
#IDSky #EpiSky #ImmunoSky
#OpenAccess: doi.org/10.1016/j.dc...

0 0 0 0
Post image

#HepatitisBvirus core protein stability is sustained by host factor PSME1, which prevents HBc degradation via the #26Sproteasome; silencing PSME1 reduces HBc levels & HBV transcription, identifying PSME1 as a novel #biomarker for chronic #HBV.

#OpenAccess: doi.org/10.1016/j.ge...

0 0 0 0
Preview
Virus-Hunter Vaccine Shows Promise in Mice for Chronic HBV Infection | Docwire News In chronic HBV carrier mice, SHARP vaccine variants showed promise toward durable viral control.

A novel innovative virus-hunter #vaccine demonstrated the ability to actively capture viruses and overcome the tolerogenic immune microenvironment that is present with #HepatitisB virus infection.
#HBV #HepatitisBVirus

5 2 0 0
Post image

📣 Webinar announcement! 🩺 HBV Reactivation

Join me and Kristine Drozd on Thursday, March 5 at 3pm EST for this upcoming @aasldnews.bsky.social (AASLD) webinar!

➡️ Register online now at:
www.aasld.org/events-and-w...

Up-to-date guidelines for the HBV reactivation & cases
#HBV #HepatitisAwareness

0 0 0 0
Post image

Our March issue is now live at www.thelancet.com/gastrohep!

Content includes: #alcohol, #IBD, #HBV, #MASLD, #SIMD (#SIBO) + more!

#GastroSky #LiverSky #MedSky

2 3 0 0
Collage of pictures showing our team activities in clinic, comms and education

Collage of pictures showing our team activities in clinic, comms and education

Collage of pictures showing our team building activities and meetings

Collage of pictures showing our team building activities and meetings

Collage of photos showing team members in the UK, South Africa and Ghana

Collage of photos showing team members in the UK, South Africa and Ghana

Proud to be part of this inspiring team delivering #research & implementation for #hepatitisB #HBV in the lab, in #clinic and for #PublicHealth across disciplines & continents.
#WomenInSTEM #STEM #science #MedSky
🧪 @crick.ac.uk @ahri-news.bsky.social
#InternationalDayofWomenAndGirlsinScience

6 1 0 0
Infographic titled “New Hepatitis D Antibody Retesting by NHANES.” Two columns compare original vs retested anti-HDV results in HBV marker positive samples, 2007–2020. Original testing used the Diasorin ETI-AB-DELTAK-2 immunoassay and shows 23% anti-HDV positivity, 55 positives total. Retesting used the International Immunodiagnostics HDV Ab (IID HDV Ab) ELISA and shows less than 1% positivity, 2 positives total. The center panel highlights the large drop after retesting and asks whether retesting may underestimate true HDV prevalence.

Infographic titled “New Hepatitis D Antibody Retesting by NHANES.” Two columns compare original vs retested anti-HDV results in HBV marker positive samples, 2007–2020. Original testing used the Diasorin ETI-AB-DELTAK-2 immunoassay and shows 23% anti-HDV positivity, 55 positives total. Retesting used the International Immunodiagnostics HDV Ab (IID HDV Ab) ELISA and shows less than 1% positivity, 2 positives total. The center panel highlights the large drop after retesting and asks whether retesting may underestimate true HDV prevalence.

Drastic shift in NHANES anti-HDV results after retesting (2007–2020). Original testing found 55 anti-HDV positive samples among HBV marker positive samples tested. Retesting found only 2. Is this fixing false positives, or missing true low-level anti-HDV signal? #NHANES #HDV #HBV #Hepatitis

2 0 0 0

A protocol for 'MoLo' #liver #health project for the #Mongolian community in #London is now on line: a template for combining #education, healthcare & #research.
wellcomeopenresearch.org/articles/11-72

#HBV #HIV #LiverSky #IDSky #MedSky 🧪
@crick.ac.uk @uclnews.bsky.social @emilymartyn.bsky.social

4 0 0 0
Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic review Introduction: Treatment of hepatitis B virus (HBV) primarily relies on nucleos(t)ide analogues to achieve viral suppression, with tenofovir or entecavir as first-line agents. Expanding treatment and i...

Our preprint addresses therapeutic drug monitoring for #HBV #hepatitisB. It may sound niche, but is a huge clinical & research gap. Better understanding could inform better #treatment & improve outcomes. 🧪💊
#LiverSky #MedSky #IDSky #Pharmacology #TDM #tenofovir
www.researchsquare.com/article/rs-8...

3 1 0 0
Preview
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles This prospective cohort followed 741 people with HIV switching to long-acting intramuscular cabotegravir/rilpivirine. No hepatitis B virus (HBV) incident i

No #HBV reactivation/incident infxn in PLH w isolated anti-HBc after switching to CAB/RPV #HIV #IDSky #MedSky
academic.oup.com/cid/advance-...

7 3 1 0
Post image

Yang et al. identified a novel exhausted T-cell subset, PD-1+ CXCR6+ CD8+ T cells, which are enriched in HBV+ HCC patients and maintained by CXCL16+ macrophages.
doi.org/10.1016/j.xi...
#HepatocellularCarcinoma #hbv #immunotherapy

2 0 0 0